| EPB174 | Impact of intrinsic and extrinsic factors on the pharmacokinetics of long-acting lenacapavir for treatment of HIV | E-poster | Pharmacokinetics/pharmacodynamics/pharmacogenomics and therapeutic drug monitoring |
| EPB175 | Pharmacokinetic modeling and simulation of intramuscular and subcutaneous ibalizumab delivery | E-poster | Pharmacokinetics/pharmacodynamics/pharmacogenomics and therapeutic drug monitoring |
| EPB176 | Pharmacokinetics (PK) and tolerability of cabotegravir (CAB) and rilpivirine (RPV) long-acting (LA) intramuscular (IM) injections to the vastus lateralis (lateral thigh) muscles of healthy adult participants | E-poster | Pharmacokinetics/pharmacodynamics/pharmacogenomics and therapeutic drug monitoring |
| EPB177 | Emtricitabine triphosphate in dried blood spots predicts current HIV viremia in people living with HIV and ongoing substance use disorders | E-poster | Pharmacokinetics/pharmacodynamics/pharmacogenomics and therapeutic drug monitoring |
| PESUB22 | Pharmacokinetics of a simplified subcutaneous lenacapavir regimen versus Phase 2/3 regimen | Poster exhibition | Pharmacokinetics/pharmacodynamics/pharmacogenomics and therapeutic drug monitoring |
| PESUB23 | Simulations for once weekly dosing of oral lenacapavir | Poster exhibition | Pharmacokinetics/pharmacodynamics/pharmacogenomics and therapeutic drug monitoring |
| PESUB26 | The first-in-human clinical trial of STP0404, a novel potent HIV-1 allosteric integrase inhibitor | Poster exhibition | Pharmacokinetics/pharmacodynamics/pharmacogenomics and therapeutic drug monitoring |
| EPD111 | 'From an HCV and HIV point of view, it's been remarkable' ' Examining "safer opioid supply" (SOS) from the perspective of healthcare providers and clients in Ontario, Canada | E-poster | People who inject drugs |
| EPD112 | Oral or injectable: who's to choose? A novel decision-making context for antiretroviral therapy modalities among persons who inject drugs and clinicians in Vietnam | E-poster | People who inject drugs |
| EPD113 | Behavioral patterns of people who use synthetic psychostimulants and HIV infection risks: results of a qualitative study in St. Petersburg, Russia | E-poster | People who inject drugs |